KalVista Pharmaceuticals, Inc. (KALV) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.69 | -7.3% |
| 2024 | $-3.44 | -3.3% |
| 2023 | $-3.33 | +0.9% |
| 2022 | $-3.36 | -38.8% |
| 2021 | $-2.42 | -47.6% |
| 2020 | $-1.64 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-3.69 | -7.3% |
| 2024 | $-3.44 | -3.3% |
| 2023 | $-3.33 | +0.9% |
| 2022 | $-3.36 | -38.8% |
| 2021 | $-2.42 | -47.6% |
| 2020 | $-1.64 | — |